1-3 of 3
Thomas Helleday
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Study Investigating Karonudib in Patients with Refractory Haematological Malignancies

Stefan Deneberg, Bertil Uggla, Austin Smith, Theresa Sandvall, Maria Klockare, Olof Breuer, Ulrika Warpman Berglund, Thomas Helleday
Journal: Blood
Blood (2024) 144 (Supplement 1): 6010.
https://doi.org/10.1182/blood-2024-209387
Published: 2024
Journal Articles

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL

Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Perez Hernandez, Supriya Chakraborty, Loïc Ysebaert, Jean-Hugues François, Susan Cortez Clemente, Guy Berchem, Dimitar G. Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigné, Petr V. Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jérôme Paggetti, Etienne Moussay
Journal: Blood
Blood (2023) 141 (26): 3166–3183.
https://doi.org/10.1182/blood.2022017839
Published: 2023
Includes: Supplemental data
Journal Articles

Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma

Morten P Oksvold, PhD MSC, Ulrika Warpman Berglund, PhD, Helge Gad, PhD, Baoyan Bai, PhD, Trond Stokke, PhD, Idun D Rein, Msc, Therese Pham, Kumar Sanjiv, PhD, Geir Frode Øy, PhD, Jens Henrik Norum, PhD, Erlend B. Smeland, PhD MD, June Helen Myklebust, PhD, Thomas Helleday, PhD, Thea Kristin Våtsveen, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-140943
Published: 2020